医药中间体是指在药物合成过程中作为关键步骤的反应产物或原料物质,它们通常是化学结构较为简单的化合物,通过一系列化学反应可以转化为最终的药物成品。这些中间体在制药工业中扮演着重要角色,是实现复杂药物分子合成的关键组成部分。
特点医药中间体的研发和生产是一个复杂的过程,通常包括以下几个步骤:
随着化学合成技术的进步和新技术的应用(如绿色化学、计算机辅助设计等),医药中间体的研发与生产正朝着更加高效、环保的方向发展。同时,对药物分子结构的深入理解也为开发更有效的治疗方案提供了更多可能性。
中文名称 | 英文名称 | CAS号 | 化学式 | 结构式图片 |
---|---|---|---|---|
2-乙烯基吡嗪 | 2-vinylpyrazine | 4177-16-6 | C6H6N2 |
|
2-乙烯基吡啶 | 2-vinylpyridine | 100-69-6 | C7H7N |
|
2-乙烯基-N,N-二甲基苄胺 | N,N-dimethylaminomethylstyrene | 22826-55-7 | C11H15N |
|
2-乙炔基苯并[D]恶唑 | 2-ethynylbenzo[d]oxazole | 40176-79-2 | C9H5NO |
|
2-乙炔基吡啶 | 2-ethynylpyridine | 1945-84-2 | C7H5N |
|
2-乙炔噻吩 | 2-ethynyl-thiophene | 4298-52-6 | C6H4S |
|
2-乙炔喹啉 | 2-ethynyl-quinoline | 40176-78-1 | C11H7N |
|
2-乙炔-6-甲基吡啶 | 2-ethynyl-6-methylpyridine | 30413-58-2 | C8H7N |
|
2-乙炔-5-甲基吡啶1-氧化物 | 2-Ethynyl-5-methylpyridine 1-oxide | 499187-53-0 | C8H7NO |
|
2-乙炔-4-甲基吡啶 | 2-ethynyl-4-methylpyridine | 30413-54-8 | C8H7N |
|
2-乙炔-3-甲基噻吩 | 3-methylthiophen-2-ylacetylene | 81294-11-3 | C7H6S |
|
2-乙氧羰基氨基-5-(4-氟苄基氨基)硝基苯 | 2-ethoxycarbonylamino-5-(4-fluorobenzylamino)nitrobenzene | 150812-23-0 | C16H16FN3O4 |
|
2-乙氧基苄脒盐酸盐 | 2-ethoxy-benzamidine hydrochloride | 18637-00-8 | C9H12N2O*ClH |
|
2-乙氧基烟腈 | 2-ethoxynicotinonitrile | 14248-71-6 | C8H8N2O |
|
2-乙氧基异烟酸 | 2-ethoxyisonicotinic acid | 91940-86-2 | C8H9NO3 |
|
2-乙氧基嘧啶-4-醇 | 2-ethoxypyrimidin-4-one | 25957-58-8 | C6H8N2O2 |
|
2-乙氧基嘧啶 | 2-ethoxypyrimidine | 3739-82-0 | C6H8N2O |
|
2-乙氧基吡啶-5-硼酸 | 2-ethoxy-5-pyridineboronic acid | 612845-44-0 | C7H10BNO3 |
|
2-乙氧基吡啶-3-硼酸 | (2-ethoxypyridin-3-yl)boronic acid | 854373-97-0 | C7H10BNO3 |
|
2-乙氧基吡啶 | 2-ethoxypyridine | 14529-53-4 | C7H9NO |
|
2-乙氧基-8-甲氧基喹啉 | 2-ethoxyquinoline | 46185-83-5 | C11H11NO |
|
2-乙氧基-8-甲基喹啉 | 2-Ethoxy-8-methylquinoline | 1221793-63-0 | C12H13NO |
|
2-乙氧基-5-硝基吡啶 | 2-ethoxy-5-nitropyridine | 31594-45-3 | C7H8N2O3 |
|
2-乙氧基-5-溴吡啶-3-硼酸 | 5-Bromo-2-ethoxypyridine-3-boronic acid | 871332-98-8 | C7H9BBrNO3 |
|
2-乙氧基-5-氟嘧啶 | 2-Ethoxy-5-fluorpyrimidin | 17148-48-0 | C6H7FN2O |
|
2-乙氧基-5-嘧啶胺 | 5-Amino-2-ethoxy-pyrimidin | 73418-86-7 | C6H9N3O |
|
2-乙氧基-5-(N,N-二异丙基)氨基吡啶 | 2-Ethoxy-5-(n,n-diisopropyl)aminopyridine | 871269-05-5 | C13H22N2O |
|
2-乙氧基-5-(4-甲基-1 哌嗪磺酰基)苯甲酸 | 2-ethoxy-5-(4-methylpiperazin-1-ylsulfonyl)benzoic acid | 194602-23-8 | C14H20N2O5S |
|
2-乙氧基-4-羟基-6-甲基嘧啶 | 6-methyl-2-etoxy-4(3H)-pyrimidinone | 55996-04-8 | C7H10N2O2 |
|
2-乙氧基-4-羟基-5-氟嘧啶 | 2-Ethoxy-5-fluoro-1H-pyrimidin-4-one | 56177-80-1 | C6H7FN2O2 |
|
2-乙氧基-4-硝基吡啶 | 2-Ethoxy-4-nitropyridine | 1187732-70-2 | C7H8N2O3 |
|
2-乙氧基-4-氨基嘧啶 | 2-ethoxy-pyrimidin-4-ylamine | 3289-48-3 | C6H9N3O |
|
2-乙氧基-4-氨基吡啶 | 4-Amino-2-ethoxy-pyridin | 89943-12-4 | C7H10N2O |
|
2-乙氧基-4-氟-6-肼基嘧啶 | 2-ethoxy-4-hydrazino-6-fluoropyrimidine | 166524-66-9 | C6H9FN4O |
|
2-乙氧基-4-(N,N-二异丙基)氨基砒啶 | 2-ethoxy-4-diisopropylaminopyridine | 200064-23-9 | C13H22N2O |
|
2-乙氧基-4,6-二羟基嘧啶 | 2-ethoxy-4,6-dihydroxypyrimidine | 61636-08-6 | C6H8N2O3 |
|
2-乙氧基-4,6-二氯嘧啶 | 4,6-dichloro-2-ethoxypyrimidine | 40758-65-4 | C6H6Cl2N2O |
|
2-乙氧基-4,6-二氟嘧啶 | 2-ethoxy-4,6-difluoropyrimidine | 166524-65-8 | C6H6F2N2O |
|
2-乙氧基-3-碘吡啶 | 2-ethoxy-3-iodopyridine | 766557-60-2 | C7H8INO |
|
2-乙氧基-3-异丙基吡嗪 | 2-Ethoxy-3-isopropylpyrazine | 72797-16-1 | C9H14N2O |
|
2-乙氧基-3-乙基吡嗪 | 2-Ethoxy-3-ethylpyrazine | 35243-43-7 | C8H12N2O |
|
2-乙氧基-3,4-二氢吡喃 | 2-ethoxy-2,3-dihydro-4H-pyran | 103-75-3 | C7H12O2 |
|
2-乙氧基-3(5或6)-甲基吡嗪 | 2-(ethoxymethyl)pyrazine | 65504-94-1 | C7H10N2O |
|
2-乙氧基-2-甲基吡嗪 | (ethoxymethyl)2-phenol | 20920-83-6 | C9H12O2 |
|
2-乙氧基-1H-苯并咪唑 | 2-ethoxy-1H-benzo[d]imidazole | 22219-23-4 | C9H10N2O |
|
2-乙氧基-1-[[(2’-(1H-四唑-5-基)联苯-4-基)甲基]苯并咪唑]-7-甲酸乙酯 | methyl 2-ethoxy-1-[[2'-(1H-tetrazol-5-yl)biphenyl-4-yl]methyl]benzimidazole-7-carboxylate | 139481-69-9 | C25H22N6O3 |
|
2-乙氧基-1-[[(2'-腈基连苯-4-取代)甲基]苯并咪唑]-7-羧酸乙酯 | ethyl-2-ethoxy-1-[[(2'-cyanobiphenyl-4-yl) methyl]benzimidazole]-7-carboxylate | 139481-41-7 | C26H23N3O3 |
|
2-乙基苯并咪唑 | 2-ethylbenzimidazole | 1848-84-6 | C9H10N2 |
|
2-乙基苯并呋喃 | 2-ethylbenzofuran | 3131-63-3 | C10H10O |
|
2-乙基胺-3-甲氧基吡啶 | 2-Ethylamino-3-methoxypyridine | 912761-77-4 | C8H12N2O |
|